Volkswagen Group is working with Valeo and Mobileye to upgrade the advanced driver assistance system...
Redeye comments on Arise’s 125MW BESS divestment through its Finish subsidiary Pohjan Voima, which A...
Redeye provides some additional comments and makes positive valuation changes following GomSpace's c...
Redeye has found that InfraCom has purchased the bankruptcy estate of Koneo, a IT Service company wi...
EQL Pharma tillverkar läkemedel där patenten gått ut, så kallad generika.
In the Asian region Vitrolife faces a challenging period.
Redeye provides a comment on Scandinavian ChemoTech's recently announced collaboration with a global...
Cedergrenska AB (”Cedergrenska” eller ”Koncernen”) meddelade den 21 mars 2025 att Koncernens nyligen...
Acquiring consulting company BlakYaks at 10.7x EV/EBITA Seems to be a good growing and highly profit...
Redeye comments on Paxman’s directed issue to institutional investors, raising SEK123.
Redeye provides its initial take on Xbrane following the sale of its Cimzia biosimilar (XB003) and p...
Redeye comments on the clinical data from the SESAR study and the confusion it brought.
Luxbright AB (”Luxbright” eller ”Bolaget”) meddelade den 19 mars 2025 att Bolaget har erhållit ytter...
Redeye leaves a comment following Magle’s announcement of a randomized controlled multicenter trial ...
Q-linea’s recent progress in extending the commercial network, establishing a pipeline of ASTar eval...
